JPMorgan Mid Cap Growth Fund
Schedule of Portfolio Investments as of March 31, 2024
(Unaudited)
THE “UNAUDITED MUTUAL FUNDS HOLDINGS” LIST (“the List”) IS TO BE USED FOR REPORTING PURPOSES ONLY. IT IS NOT TO BE REPRODUCED FOR USE AS ADVERTISING OR SALES LITERATURE WITH THE GENERAL PUBLIC. The list is submitted for the general information of the shareholders of the Fund. It is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by a prospectus. The list has been created from the books and records of the Fund. Holdings are available 60 days after the fund’s fiscal quarter, using a trade date accounting convention, by contacting the appropriate service center. The list is subject to change without notice. The list is for informational purposes only and is not intended as an offer or solicitation with respect to the purchase or sale of any security. |
JPMorgan Asset Management is the marketing name for the asset management business of J.P. Morgan Chase & Co. |
J.P. Morgan Distribution Services, Inc., member FINRA. |
© J.P. Morgan Chase & Co., 2024. |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited)INVESTMENTS | SHARES (000) | VALUE ($000) |
Common Stocks — 98.6% | ||
Aerospace & Defense — 1.2% | ||
HEICO Corp., Class A | 906 | 139,452 |
Automobiles — 0.5% | ||
Thor Industries, Inc. (a) | 447 | 52,439 |
Beverages — 0.5% | ||
Constellation Brands, Inc., Class A | 219 | 59,411 |
Biotechnology — 5.0% | ||
Alnylam Pharmaceuticals, Inc. * | 440 | 65,760 |
Amicus Therapeutics, Inc. * | 3,025 | 35,631 |
Apellis Pharmaceuticals, Inc. * | 693 | 40,746 |
Exact Sciences Corp. * | 1,407 | 97,201 |
Exelixis, Inc. * | 2,640 | 62,637 |
Natera, Inc. * | 1,608 | 147,054 |
Neurocrine Biosciences, Inc. * | 656 | 90,506 |
Sarepta Therapeutics, Inc. * | 253 | 32,784 |
572,319 | ||
Building Products — 2.7% | ||
Simpson Manufacturing Co., Inc. | 358 | 73,574 |
Trane Technologies plc | 806 | 241,906 |
315,480 | ||
Capital Markets — 9.6% | ||
Ares Management Corp. | 1,137 | 151,158 |
FactSet Research Systems, Inc. (a) | 244 | 110,782 |
Interactive Brokers Group, Inc., Class A | 913 | 102,028 |
KKR & Co., Inc. | 1,618 | 162,753 |
LPL Financial Holdings, Inc. | 377 | 99,659 |
Moody's Corp. | 268 | 105,369 |
MSCI, Inc. | 221 | 124,189 |
Raymond James Financial, Inc. | 808 | 103,719 |
Robinhood Markets, Inc., Class A * | 1,963 | 39,511 |
Tradeweb Markets, Inc., Class A | 985 | 102,621 |
1,101,789 | ||
Commercial Services & Supplies — 4.1% | ||
Cintas Corp. | 238 | 163,351 |
Copart, Inc. * | 4,127 | 239,037 |
MSA Safety, Inc. | 373 | 72,229 |
474,617 | ||
Communications Equipment — 0.6% | ||
Arista Networks, Inc. * | 257 | 74,592 |
Construction & Engineering — 1.3% | ||
Quanta Services, Inc. | 590 | 153,159 |
Construction Materials — 0.7% | ||
Eagle Materials, Inc. | 283 | 76,999 |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)INVESTMENTS | SHARES (000) | VALUE ($000) |
Common Stocks — continued | ||
Distributors — 0.9% | ||
Pool Corp. (a) | 256 | 103,368 |
Diversified Consumer Services — 0.9% | ||
Bright Horizons Family Solutions, Inc. * | 934 | 105,824 |
Electrical Equipment — 2.5% | ||
AMETEK, Inc. | 613 | 112,071 |
Hubbell, Inc. | 264 | 109,751 |
Vertiv Holdings Co., Class A | 830 | 67,784 |
289,606 | ||
Electronic Equipment, Instruments & Components — 3.2% | ||
Amphenol Corp., Class A | 1,326 | 152,891 |
Jabil, Inc. (a) | 648 | 86,821 |
Keysight Technologies, Inc. * | 392 | 61,342 |
Teledyne Technologies, Inc. * | 156 | 66,816 |
367,870 | ||
Energy Equipment & Services — 1.1% | ||
TechnipFMC plc (United Kingdom) (a) | 5,000 | 125,550 |
Entertainment — 1.0% | ||
Take-Two Interactive Software, Inc. * | 785 | 116,592 |
Financial Services — 1.3% | ||
Remitly Global, Inc. * | 3,684 | 76,406 |
Rocket Cos., Inc., Class A * (a) | 4,959 | 72,161 |
148,567 | ||
Ground Transportation — 2.5% | ||
JB Hunt Transport Services, Inc. | 454 | 90,460 |
Saia, Inc. * | 191 | 111,974 |
Uber Technologies, Inc. * | 1,098 | 84,542 |
286,976 | ||
Health Care Equipment & Supplies — 6.2% | ||
Align Technology, Inc. * | 357 | 117,128 |
Cooper Cos., Inc. (The) | 731 | 74,191 |
Dexcom, Inc. * | 1,491 | 206,776 |
IDEXX Laboratories, Inc. * | 152 | 81,939 |
Inspire Medical Systems, Inc. * | 256 | 54,908 |
ResMed, Inc. | 322 | 63,871 |
Shockwave Medical, Inc. * | 355 | 115,504 |
714,317 | ||
Health Care Providers & Services — 2.3% | ||
Acadia Healthcare Co., Inc. * | 904 | 71,623 |
Centene Corp. * | 1,068 | 83,832 |
McKesson Corp. | 208 | 111,497 |
266,952 | ||
Hotels, Restaurants & Leisure — 6.3% | ||
Chipotle Mexican Grill, Inc. * | 26 | 74,701 |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)INVESTMENTS | SHARES (000) | VALUE ($000) |
Common Stocks — continued | ||
Hotels, Restaurants & Leisure — continued | ||
Domino's Pizza, Inc. | 333 | 165,565 |
DoorDash, Inc., Class A * | 1,624 | 223,640 |
Hilton Worldwide Holdings, Inc. | 647 | 137,936 |
Las Vegas Sands Corp. | 1,227 | 63,447 |
Royal Caribbean Cruises Ltd. * (a) | 459 | 63,798 |
729,087 | ||
Household Durables — 0.8% | ||
Garmin Ltd. | 421 | 62,597 |
Helen of Troy Ltd. * (a) | 292 | 33,695 |
96,292 | ||
Insurance — 0.8% | ||
Arthur J Gallagher & Co. (a) | 355 | 88,726 |
IT Services — 3.9% | ||
Gartner, Inc. * | 361 | 171,761 |
Globant SA * | 475 | 95,910 |
MongoDB, Inc. * (a) | 335 | 120,161 |
Snowflake, Inc., Class A * | 367 | 59,328 |
447,160 | ||
Life Sciences Tools & Services — 5.6% | ||
Agilent Technologies, Inc. | 1,516 | 220,580 |
IQVIA Holdings, Inc. * | 776 | 196,215 |
Mettler-Toledo International, Inc. * | 74 | 98,582 |
West Pharmaceutical Services, Inc. | 335 | 132,790 |
648,167 | ||
Machinery — 3.3% | ||
Esab Corp. | 396 | 43,811 |
Ingersoll Rand, Inc. | 1,347 | 127,928 |
ITT, Inc. | 1,084 | 147,421 |
Westinghouse Air Brake Technologies Corp. | 406 | 59,102 |
378,262 | ||
Media — 1.7% | ||
Trade Desk, Inc. (The), Class A * | 2,216 | 193,734 |
Oil, Gas & Consumable Fuels — 2.0% | ||
Cheniere Energy, Inc. | 852 | 137,373 |
EOG Resources, Inc. | 688 | 87,955 |
225,328 | ||
Personal Care Products — 0.7% | ||
elf Beauty, Inc. * | 434 | 85,093 |
Pharmaceuticals — 0.5% | ||
Royalty Pharma plc, Class A | 1,839 | 55,844 |
Professional Services — 1.4% | ||
Booz Allen Hamilton Holding Corp. | 1,082 | 160,666 |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)INVESTMENTS | SHARES (000) | VALUE ($000) |
Common Stocks — continued | ||
Semiconductors & Semiconductor Equipment — 5.2% | ||
Astera Labs, Inc. * | 285 | 21,108 |
Entegris, Inc. | 931 | 130,830 |
Lam Research Corp. | 89 | 86,289 |
Marvell Technology, Inc. | 980 | 69,483 |
Monolithic Power Systems, Inc. | 197 | 133,692 |
ON Semiconductor Corp. * | 712 | 52,350 |
Onto Innovation, Inc. * | 191 | 34,674 |
Rambus, Inc. * | 1,075 | 66,440 |
594,866 | ||
Software — 11.5% | ||
Confluent, Inc., Class A * | 3,204 | 97,792 |
Coreweave, Inc. ‡ * (b) | 29 | 8,904 |
Crowdstrike Holdings, Inc., Class A * | 913 | 292,762 |
CyberArk Software Ltd. * | 196 | 52,114 |
Datadog, Inc., Class A * | 926 | 114,485 |
Elastic NV * | 612 | 61,305 |
Gitlab, Inc., Class A * | 948 | 55,272 |
HubSpot, Inc. * | 278 | 174,414 |
Palantir Technologies, Inc., Class A * | 2,277 | 52,396 |
Palo Alto Networks, Inc. * | 248 | 70,404 |
Procore Technologies, Inc. * | 1,215 | 99,823 |
Synopsys, Inc. * | 178 | 101,504 |
Workday, Inc., Class A * | 348 | 94,961 |
Zoom Video Communications, Inc., Class A * | 731 | 47,789 |
1,323,925 | ||
Specialty Retail — 5.6% | ||
AutoZone, Inc. * | 16 | 51,268 |
Burlington Stores, Inc. * | 369 | 85,577 |
Floor & Decor Holdings, Inc., Class A * (a) | 798 | 103,427 |
Ross Stores, Inc. | 1,762 | 258,596 |
Tractor Supply Co. (a) | 559 | 146,330 |
645,198 | ||
Textiles, Apparel & Luxury Goods — 0.5% | ||
Lululemon Athletica, Inc. * | 154 | 60,155 |
Trading Companies & Distributors — 0.7% | ||
Air Lease Corp. | 1,635 | 84,095 |
Total Common Stocks (Cost $7,833,048) | 11,362,477 | |
Short-Term Investments — 3.4% | ||
Investment Companies — 1.3% | ||
JPMorgan Prime Money Market Fund Class IM Shares, 5.43% (c) (d) (Cost $146,540) | 146,509 | 146,567 |
Investment of Cash Collateral from Securities Loaned — 2.1% | ||
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 5.48% (c) (d) | 222,373 | 222,373 |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)INVESTMENTS | SHARES (000) | VALUE ($000) |
Short-Term Investments — continued | ||
Investment of Cash Collateral from Securities Loaned — continued | ||
JPMorgan U.S. Government Money Market Fund Class IM Shares, 5.25% (c) (d) | 26,701 | 26,701 |
Total Investment of Cash Collateral from Securities Loaned (Cost $249,153) | 249,074 | |
Total Short-Term Investments (Cost $395,693) | 395,641 | |
Total Investments — 102.0% (Cost $8,228,741) | 11,758,118 | |
Liabilities in Excess of Other Assets — (2.0)% | (234,563 ) | |
NET ASSETS — 100.0% | 11,523,555 |
Percentages indicated are based on net assets. |
‡ | Value determined using significant unobservable inputs. |
* | Non-income producing security. |
(a) | The security or a portion of this security is on loan at March 31, 2024. The total value of securities on loan at March 31, 2024 is $244,791. |
(b) | Restricted security. See Note 2.B. |
(c) | Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
(d) | The rate shown is the current yield as of March 31, 2024. |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)(Dollar values in thousands)A. Valuation of Investments— Investments are valued in accordance with U.S. generally accepted accounting principles (“GAAP”) and the Fund's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the “Board”), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the Investment Company Act of 1940, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Funds on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of investments held in the Funds. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset values (“NAV”) of the Fund are calculated on a valuation date.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s NAV per share as of the report date.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Fund's investments are summarized into the three broad levels listed below.
•
Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.
•
Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
•
Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Fund's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments (“SOI”):
Level 1 Quoted prices | Level 2 Other significant observable inputs | Level 3 Significant unobservable inputs | Total | |
Investments in Securities | ||||
Common Stocks | ||||
Aerospace & Defense | $139,452 | $— | $— | $139,452 |
Automobiles | 52,439 | — | — | 52,439 |
Beverages | 59,411 | — | — | 59,411 |
Biotechnology | 572,319 | — | — | 572,319 |
Building Products | 315,480 | — | — | 315,480 |
Capital Markets | 1,101,789 | — | — | 1,101,789 |
Commercial Services & Supplies | 474,617 | — | — | 474,617 |
Communications Equipment | 74,592 | — | — | 74,592 |
Construction & Engineering | 153,159 | — | — | 153,159 |
Construction Materials | 76,999 | — | — | 76,999 |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)(Dollar values in thousands)Level 1 Quoted prices | Level 2 Other significant observable inputs | Level 3 Significant unobservable inputs | Total | |
Distributors | $103,368 | $— | $— | $103,368 |
Diversified Consumer Services | 105,824 | — | — | 105,824 |
Electrical Equipment | 289,606 | — | — | 289,606 |
Electronic Equipment, Instruments & Components | 367,870 | — | — | 367,870 |
Energy Equipment & Services | 125,550 | — | — | 125,550 |
Entertainment | 116,592 | — | — | 116,592 |
Financial Services | 148,567 | — | — | 148,567 |
Ground Transportation | 286,976 | — | — | 286,976 |
Health Care Equipment & Supplies | 714,317 | — | — | 714,317 |
Health Care Providers & Services | 266,952 | — | — | 266,952 |
Hotels, Restaurants & Leisure | 729,087 | — | — | 729,087 |
Household Durables | 96,292 | — | — | 96,292 |
Insurance | 88,726 | — | — | 88,726 |
IT Services | 447,160 | — | — | 447,160 |
Life Sciences Tools & Services | 648,167 | — | — | 648,167 |
Machinery | 378,262 | — | — | 378,262 |
Media | 193,734 | — | — | 193,734 |
Oil, Gas & Consumable Fuels | 225,328 | — | — | 225,328 |
Personal Care Products | 85,093 | — | — | 85,093 |
Pharmaceuticals | 55,844 | — | — | 55,844 |
Professional Services | 160,666 | — | — | 160,666 |
Semiconductors & Semiconductor Equipment | 594,866 | — | — | 594,866 |
Software | 1,315,021 | — | 8,904 | 1,323,925 |
Specialty Retail | 645,198 | — | — | 645,198 |
Textiles, Apparel & Luxury Goods | 60,155 | — | — | 60,155 |
Trading Companies & Distributors | 84,095 | — | — | 84,095 |
Total Common Stocks | 11,353,573 | — | 8,904 | 11,362,477 |
Short-Term Investments | ||||
Investment Companies | 146,567 | — | — | 146,567 |
Investment of Cash Collateral from Securities Loaned | 249,074 | — | — | 249,074 |
Total Short-Term Investments | 395,641 | — | — | 395,641 |
Total Investments in Securities | $11,749,214 | $— | $8,904 | $11,758,118 |
B. Investment Transactions with Affiliates— The Fund invested in Underlying Funds advised by the Adviser. An issuer which is under common control with the Fund may be considered an affiliate. The Fund assumes the issuers listed in the table below to be affiliated issuers. The Underlying Funds’ distributions may be reinvested into such Underlying Funds. Reinvestment amounts are included in the purchases at cost amounts in the table below.
For the period ended March 31, 2024 | |||||||||
Security Description | Value at June 30, 2023 | Purchases at Cost | Proceeds from Sales | Net Realized Gain (Loss) | Change in Unrealized Appreciation/ (Depreciation) | Value at March 31, 2024 | Shares at March 31, 2024 | Dividend Income | Capital Gain Distributions |
JPMorgan Prime Money Market Fund Class IM Shares, 5.43% (a) (b) | $128,783 | $1,297,373 | $1,279,626 | $23 | $14 | $146,567 | 146,509 | $5,894 | $— |
JPMorgan Mid Cap Growth Fund
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF March 31, 2024 (Unaudited) (continued)(Dollar values in thousands)For the period ended March 31, 2024 | |||||||||
Security Description | Value at June 30, 2023 | Purchases at Cost | Proceeds from Sales | Net Realized Gain (Loss) | Change in Unrealized Appreciation/ (Depreciation) | Value at March 31, 2024 | Shares at March 31, 2024 | Dividend Income | Capital Gain Distributions |
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 5.48% (a) (b) | $137,903 | $1,085,500 | $1,001,000 | $45 | $(75 ) | $222,373 | 222,373 | $8,715 | $— |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 5.25% (a) (b) | 23,086 | 449,843 | 446,228 | — | — | 26,701 | 26,701 | 1,096 | — |
Total | $289,772 | $2,832,716 | $2,726,854 | $68 | $(61 ) | $395,641 | $15,705 | $— |
(a) | Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
(b) | The rate shown is the current yield as of March 31, 2024. |